The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.
about
Oleanolic acid ameliorates high glucose-induced endothelial dysfunction via PPARδ activation.Treatment options for nonalcoholic steatohepatitis - a safety evaluation.Peroxisome proliferator-activated receptors in cardiac energy metabolism and cardiovascular disease.The role of perivascular adipose tissue in obesity-induced vascular dysfunctionAntihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation.The Positive Regulation of eNOS Signaling by PPAR Agonists in Cardiovascular Diseases.Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease.Chinese innovation in cardiovascular drug discovery.PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia.Effect of berberine on PPARα-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV.Pharmacological Activation of Peroxisome Proliferator-Activated Receptor {Delta} Increases Sphingomyelin Synthase Activity in THP-1 Macrophage-Derived Foam Cell.
P2860
Q37571295-414DB4B2-F6DB-49DC-BE1F-73F336A3C968Q38713765-B456B129-04B8-4EC6-9B3D-73E9EC6CA0F5Q38817895-4D3BB497-C177-4AB4-B76C-1817987F14A9Q38985853-429A0348-8FC9-4B99-A2AA-F6D103ADA185Q39018398-FAC8D9FB-722C-4E93-89CD-765B7E3A38F4Q39185669-2A6369B9-463A-4B1B-AB37-093CE6DCF78CQ41640163-2E3DACCF-5730-4351-9093-2F227F6D4EC2Q43145398-899D853B-8A3E-4321-A04D-9AF0F845685FQ48247479-A5AC5AF3-4A9C-40FE-9EC9-225DD2D0AECFQ51024129-87D7265E-8A26-4B3C-81C3-142543876BEFQ51713067-64216934-EB73-493E-805E-BC1CFC9CADFA
P2860
The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The peroxisome proliferator-ac ...... efits and clinical challenges.
@en
type
label
The peroxisome proliferator-ac ...... efits and clinical challenges.
@en
prefLabel
The peroxisome proliferator-ac ...... efits and clinical challenges.
@en
P2860
P50
P356
P1476
The peroxisome proliferator-ac ...... nefits and clinical challenges
@en
P2093
Wai San Cheang
P2860
P304
P356
10.1111/BPH.13029
P407
P577
2015-01-23T00:00:00Z